PubMed Health⌕ Search

Biomedical subjects

L Garnier

Publications and source records attributed to L Garnier.

27 records · Page 2Linked to original sources

[The role of splanchnic afferences of the duodeno-pancreatic zone in vomiting].

The duodenum and pancreas of the cat send splanchnic afferences via the anterior nerve branches. The latter run along the coeliac artery. The stimulation of those pathways induced pattern alteration of the respiratory command signal. After an interruption of phrenic nerve discharge, the respiratory function was mobilized to empty the stomach. It is suggested that the duodenum is systematically involved in all types of vomiting.

Afferent Pathways↗

[Preliminary results on the splanchnico-laryngeal reflex in the cat].

Electrical stimulation of low threshold splanchnic afferent nerves in lightly anesthetized cat results in phrenic and recurrent laryngeal nerve responses. Both phrenic and recurrent laryngeal inspiratory nerve activities are inhibited, whereas expiratory recurrent nerve activity is triggered and even increased. The significance of this reflex is discussed in relation to laryngeal adductor muscle contractions and the abdominal pressure increase.

Afferent Pathways↗

[Patients with the highest cardiovascular risk are the least compliant with their antihypertensive therapy (DESIR study)].

AIM OF THE STUDY: To identify the sociodemographic and clinical profile of hypertensive patients who are not compliant with their antihypertensive treatment. METHODS: each cardiologist described his or her next 4 hypertensive patients from a clinical standpoint and gave them a self-administered compliance questionnaire developed by the French Committee to Fight Hypertension, which they returned directly to the analysis center using a postage-paid reply envelope. RESULTS: 1965 patients 63.9 +/- 12.1 years old, 55.3% of whom were male, were included in the study. According to the specific questionnaire, compliance is definitely satisfactory in 35.9% of patients, is probably satisfactory in 28.3%, is probably poor in 19.4% and is definitely poor in 16.4%. Poor compliance is more frequent among men (38.1 vs. 33.4%; p < 0.05), overweight or obese patients (35.8 and 43.0% vs. 30.0%; p < 0.001), diabetics (46.7 vs. 32.3%; p < 0.0001), dyslipidemic patients (39.3 vs. 31.8%; p < 0.001), smokers (50.2 vs. 33.8%; p < 0.0001), those whose father died of cardiovascular causes before 55 years of age (51.6 vs. 34.1%; p < 0.0001) or those with a previous history of CV events (40.6 vs. 32.8%; p < 0.001). The rate of poor compliance increases with the number of risk factors: 27.3% with no risk factor other than high BP, 32.2% with one, 37.2 with 2 and 51.5% with 3 or more (p < 0.0001). Multifactorial analyses confirm the independent effect of obesity, diabetes, smoking, and father's CV death before age 55 on patient compliance. CONCLUSION: patients with the highest CV risk are those who are the least compliant with their antihypertensive treatment. These results raise the question of the appropriateness of the prevention information given to the most at-risk patients.

Antihypertensive Agents↗